Results 21 to 30 of about 6,107 (224)

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.

PLoS ONE
The treatment of choice for hepatorenal syndrome-acute kidney injury (HRS-AKI) is vasoconstrictor therapy in combination with albumin, preferably norepinephrine or terlipressin as recommended by recent guidelines.
Jody C Olson, Ram M Subramanian
doaj   +2 more sources

The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review [PDF]

BMC Anesthesiology
Background Intraoperative hypotension is a recognized risk factor for delayed graft function (DGF) after kidney transplantation and may compromise both short- and long-term allograft outcomes.
Wen-He Yang, Xin-Lu Chang, Liang Zhang, Lei Wan, Yi Cheng, Yi-Chen Zhu, Fu-Shan Xue   +6 more
doaj   +2 more sources

Terlipressin for septic shock patients: a meta-analysis of randomized controlled study [PDF]

Journal of Intensive Care, 2019
Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu, Huibin Huang, Xiuming Xi, Bin Du   +3 more
doaj   +2 more sources

Efficacy of low doses of terlipressin to prevent intra-operative blood loss in obstetrics

Вестник анестезиологии и реаниматологии, 2020
The use of modern blood-saving technologies is one of the effective methods of preventing intra-operative bleeding in obstetric practice, however, the effect of local use of terlipressin to reduce blood loss is not sufficiently investigated.The objective:
Yu. S. Аleksandrovich, A. V. Rostovtsev, E. S. Kononova, K. V. Pshenisnov, T. I. Аkimenko   +4 more
doaj   +3 more sources

Terlipressin

Reactions Weekly, 2008
&NA;
  +5 more sources

Challenges in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A US Chart Review of Treatment Patterns and Survival Outcomes. [PDF]

JGH Open
ABSTRACT Background Treatments for hepatorenal syndrome with acute kidney injury (HRS‐AKI) that are not FDA‐approved have been widely used in the United States (US) with variable outcomes. This study describes the practice patterns, outcomes, and healthcare utilization around vasopressor use before terlipressin approval in 2022. Methods A retrospective
Sanyal AJ, Reddy KR, Brown KA, Landis CS, Cullaro G, Huang X, Kelkar SS, Raina R, Corman S, Kebede N, Edmundson P, Jamil K, Allegretti AS.   +12 more
europepmc   +2 more sources

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older

Annals of Hepatology, 2023
Introduction and Objectives: Clinical data for older patients with advanced liver disease are limited. This post hoc analysis evaluated the efficacy and safety of terlipressin in patients aged ≥65 years with hepatorenal syndrome using data from 3 Phase ...
Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil   +8 more
doaj   +1 more source

Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome

AAPS Open, 2022
The objective of this population pharmacokinetics (PK) analysis was to characterize the PK of terlipressin and its active metabolite, lysine-vasopressin (L-VP), in patients with hepatorenal syndrome (HRS), following intravenous administration of ...
Xiaofeng Wang, Khurram Jamil
doaj   +1 more source

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study

Scientific Reports, 2022
Terlipressin with albumin, the recommended treatment for hepatorenal syndrome-acute kidney injury (HRS-AKI), is associated with adverse events. Furthermore, the course of AKI in patients with acute-on-chronic liver failure (ACLF) is unknown.
Anand V. Kulkarni, Sowmya Tirumalige Ravikumar, Harshvardhan Tevethia, Madhumita Premkumar, Karan Kumar, Mithun Sharma, Rajesh Gupta, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy   +8 more
doaj   +1 more source

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence

Canadian Journal of Gastroenterology and Hepatology, 2020
Ascites, a common complication in cirrhosis, is prone to the development of acute kidney injury or hepatorenal syndrome and can be complicated by circulatory dysfunction after paracentesis.
Zhaohui Bai, Yang An, Xiaozhong Guo, Rolf Teschke, Nahum Méndez-Sánchez, Hongyu Li, Xingshun Qi   +6 more
doaj   +1 more source